Diligence memo · auto-generated · as of July 2, 2026
Cardiovascular Systems Inc
Cardiovascular Systems Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Cardiovascular Systems Inc operates in Other Health Care, based in St. Paul.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cardiovascular Systems Inc has raised $59M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $14M on 2010-12-03.
Most recent recorded round closed around 2010-12-03.
Valuation (modeled)modeled
Provath models Cardiovascular Systems Inc at approximately $272M (range $17M–$1.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.34× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 1 months.
Last raise 15.6 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 93% of Other Health Care peers (5377 compared).
Modeled value ranks above 90% of those peers.
Closest niche peers: Barrx Medical Inc, Icad Inc, Cas Medical Systems Inc, Cardiosolutions Inc, Ophthonix Inc.
Peoplefiled
19 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.